why choose us

First received: June 07, 2023

Clinical Trial: ORB-011 In Patients With Advanced Solid Tumors

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Advanced Solid Cancer

Study Type: INTERVENTIONAL


Official Title: ORB-011 In Patients With Advanced Solid Tumors

Brief Summary: The goal of this clinical research study is to determine if an investigational new drug, named ORB-011, developed by Orionis Biosciences is safe and can be tolerated in people diagnosed with an advanced solid tumor.The study also aims to find the biologically optimal dose of the study medicine by assessing the safety and potential activity in the treatment of solid tumors.There are three phases to this study: screening, treatment and end of treatment.

Read more